Shenzhen - Delayed Quote CNY

Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)

16.13 +0.04 (+0.25%)
At close: April 26 at 3:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Yuping Cao GM & Chairman of the Board -- -- 1964
Mr. Li Qun Wang Secretary & Deputy GM -- -- 1988
Mr. Weicheng Liu Deputy General Manager -- -- 1981

Nanjing Hicin Pharmaceutical Co., Ltd.

No.1 Hengfa Road
Economic and Technological Development Zone
Nanjing, 210046
China
86 25 8322 2911 https://www.hicin.cn/page1/index1
Sector: 
Healthcare

Description

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China. It offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. The company also provides technical transferring services. In addition, it offers supply chain management services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is headquartered in Nanjing, China.

Corporate Governance

Nanjing Hicin Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 25, 2022
    Ex-Dividend Date

Upcoming Events

Related Tickers

603351.SS Nanjing Well Pharmaceutical Group Co.,Ltd.
23.76
-1.53%
 
600557.SS Jiangsu Kanion Pharmaceutical Co.,Ltd.
19.80
+2.48%
 
300725.SZ PharmaBlock Sciences (Nanjing), Inc.
33.03
+4.13%
 
603707.SS Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
13.24
+0.46%